Alerts will be sent to your verified email
Verify Email
RAJLXIN
|
Rajlaxmi Industries
|
Astal Laboratories
|
Novelix Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.15 % | 5.65 % | -17.5 % |
|
5yr average Equity Multiplier
|
1.16 | 1.45 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
0.22 | 0.4 | 0.84 |
|
5yr Avg Net Profit Margin
|
0.85 % | 3.54 % | -14.11 % |
|
Price to Book
|
n/a | 2.04 | 5.13 |
|
P/E
|
n/a | 8.95 | 92.44 |
|
5yr Avg Cash Conversion Cycle
|
320.18 Days | 83.93 Days | 29.1 Days |
|
Inventory Days
|
27.88 Days | 12.25 Days | 34.04 Days |
|
Days Receivable
|
1710.81 Days | 123.54 Days | 55.38 Days |
|
Days Payable
|
395.74 Days | 125.63 Days | 55.7 Days |
|
5yr Average Interest Coverage Ratio
|
490.02 | 21.93 | -17.77 |
|
5yr Avg ROCE
|
0.21 % | 7.95 % | -15.4 % |
|
5yr Avg Operating Profit Margin
|
-14.19 % | 4.11 % | -16.49 % |
|
5 yr average Debt to Equity
|
0.01 | 0.08 | 0.05 |
|
5yr CAGR Net Profit
|
-100.0 % | 289.2 % | 35.78 % |
|
5yr Average Return on Assets
|
0.09 % | 3.24 % | -13.36 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
1.63 % | 18.19 % | 53.33 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-49.02 % | -49.99 % | -13.59 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rajlaxmi Industries
|
Astal Laboratories
|
Novelix Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|